We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
1676
GSK
GSK
$102B
$295K 0.01%
6,597
-10,636
-62% -$483K
HESM icon
1677
Hess Midstream
HESM
$5.22B
$294K ﹤0.01%
+13,124
New +$283K
NAVI icon
1678
Navient
NAVI
$813M
$294K ﹤0.01%
20,563
+230
+1% +$2.83K
RXL icon
1679
ProShares Ultra Health Care
RXL
$90.3M
$294K ﹤0.01%
7,378
-6,666
-47% -$263K
UEC icon
1680
Uranium Energy
UEC
$5.65B
$294K ﹤0.01%
102,633
+28,258
+38% +$61.7K
ABR icon
1681
Arbor Realty Trust
ABR
$1B
$293K ﹤0.01%
18,451
+12,846
+229% +$198K
PSEC icon
1682
Prospect Capital
PSEC
$1.15B
$293K ﹤0.01%
38,233
+37,033
+3,086% +$256K
SLGN icon
1683
Silgan Holdings
SLGN
$4.36B
$293K ﹤0.01%
6,965
-9,292
-57% -$363K
FTS icon
1684
Fortis
FTS
$28.6B
$292K ﹤0.01%
6,764
+5,435
+409% +$223K
SKY icon
1685
Champion Homes
SKY
$5.12B
$292K ﹤0.01%
6,449
-6,122
-49% -$246K
CADE
1686
DELISTED
Cadence Bank
CADE
$291K ﹤0.01%
8,952
-2,271
-20% -$70K
OSS icon
1687
One Stop Systems
OSS
$320M
$291K ﹤0.01%
45,890
+45,325
+8,022% +$277K
AIN icon
1688
Albany International
AIN
$1.78B
$290K ﹤0.01%
3,475
+901
+35% +$71.5K
OZON
1689
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$290K ﹤0.01%
5,173
+4,957
+2,295% +$273K
BHVN
1690
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$290K ﹤0.01%
4,242
-1,797
-30% -$145K
FOLD
1691
DELISTED
Amicus Therapeutics
FOLD
$289K ﹤0.01%
29,323
+4,015
+16% +$62.1K
RGLD icon
1692
Royal Gold
RGLD
$19.7B
$289K ﹤0.01%
2,682
-5,127
-66% -$547K
CSOD
1693
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$289K ﹤0.01%
6,612
-334
-5% -$15.4K
ABCB icon
1694
Ameris Bancorp
ABCB
$5.9B
$288K ﹤0.01%
5,484
-3,086
-36% -$147K
ARI
1695
Apollo Commercial Real Estate
ARI
$889M
$288K ﹤0.01%
20,550
+6,167
+43% +$79.1K
MC icon
1696
Moelis & Co
MC
$4.93B
$288K ﹤0.01%
5,255
+3,393
+182% +$182K
ETRN
1697
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$288K ﹤0.01%
35,284
+3,986
+13% +$30.3K
KBWB icon
1698
Invesco KBW Bank ETF
KBWB
$6.79B
$287K ﹤0.01%
+4,643
New +$267K
NBHC icon
1699
National Bank Holdings
NBHC
$1.92B
$287K ﹤0.01%
7,232
+1,611
+29% +$60.3K
SMCI icon
1700
Super Micro Computer
SMCI
$20.4B
$287K ﹤0.01%
73,440
+2,580
+4% +$8.78K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.